The original article published by Radio-Canada / CBC discusses the rising popularity of the drug Ozempic in Canada, primarily prescribed for diabetics but increasingly used for weight loss. The drug’s extensive advertising campaign, including ads on streetcars, buses, and subway stations, has caught the attention of pharmacist Alexander Mihaila, who expresses frustration with the expectations created by the ads.
Many individuals purchasing Ozempic at pharmacies are seeking weight loss rather than diabetes treatment. Health Canada acknowledges the increased demand for the drug but has not received an application to license it for weight loss.
Concerns are raised about potential supply problems that could negatively impact patients relying on Ozempic for diabetes management.
